Found 3 results
Filters: Author is C. Qiu  [Clear All Filters]
C. Qiu, Peng, W. K., Shi, F., and Zhang, T., Bottom-up assembly of RNA nanoparticles containing phi29 motor pRNA to silence the asthma STAT5b gene, vol. 11, pp. 3236-3245, 2012.
Castanotto D and Rossi JJ (2009). The promises and pitfalls of RNA-interference-based therapeutics. Nature 457: 426-433. PMid:19158789 PMCid:2702667   Chen C, Sheng S, Shao Z and Guo P (2000). A dimer as a building block in assembling RNA. A hexamer that gears bacterial virus phi29 DNA-translocating machinery. J. Biol. Chem. 275: 17510-17516. PMid:10748150   Dorsett Y and Tuschl T (2004). siRNAs: applications in functional genomics and potential as therapeutics. Nat. Rev. Drug. Discov. 3: 318-329. PMid:15060527   Elbashir SM, Lendeckel W and Tuschl T (2001). RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev. 15: 188-200. PMid:11157775 PMCid:312613   Guo P (2010). The emerging field of RNA nanotechnology. Nat. Nanotechnol. 5: 833-842. PMid:21102465 PMCid:3149862   Guo S, Tschammer N, Mohammed S and Guo P (2005). Specific delivery of therapeutic RNAs to cancer cells via the dimerization mechanism of phi29 motor pRNA. Hum. Gene Ther. 16: 1097-1109. PMid:16149908 PMCid:2837361   Kraus E, James W and Barclay AN (1998). Cutting edge: novel RNA ligands able to bind CD4 antigen and inhibit CD4+ T lymphocyte function. J. Immunol. 160: 5209-5212. PMid:9605115   Lee TJ, Schwartz C and Guo P (2009). Construction of bacteriophage phi29 DNA packaging motor and its applications in nanotechnology and therapy. Ann. Biomed. Eng. 37: 2064-2081. PMid:19495981 PMCid:2855900   Maes T, Tournoy KG and Joos GF (2011). Gene therapy for allergic airway diseases. Curr. Allergy Asthma Rep. 11: 163-172. PMid:21243453   North ML, Khanna N, Marsden PA, Grasemann H, et al. (2009). Functionally important role for arginase 1 in the airway hyperresponsiveness of asthma. Am. J. Physiol. Lung Cell Mol. Physiol. 296: L911-L920. PMid:19286931   Shu D, Huang LP, Hoeprich S and Guo P (2003). Construction of phi29 DNA-packaging RNA monomers, dimers, and trimers with variable sizes and shapes as potential parts for nanodevices. J. Nanosci. Nanotechnol. 3: 295-302. PMid:14598442   Shu D, Moll WD, Deng Z, Mao C, et al. (2004). Bottom-up Assembly of RNA Arrays and Superstructures as Potential Parts in Nanotechnology. Nano Lett. 4: 1717-1723. PMid:21171616 PMCid:3010238   Shu Y, Shu D, Diao Z, Shen G, et al. (2009). Fabrication of Polyvalent Therapeutic RNA Nanoparticles for Specific Delivery of siRNA, Ribozyme and Drugs to Targeted Cells for Cancer Therapy. IEEE NIH Life Sci. Syst. Appl. Workshop 2009: 9-12.   Tarapore P, Shu Y, Guo P and Ho SM (2011). Application of phi29 motor pRNA for targeted therapeutic delivery of siRNA silencing metallothionein-IIA and survivin in ovarian cancers. Mol. Ther. 19: 386-394. PMid:21063391 PMCid:3034850   Zhang HM, Su Y, Guo S, Yuan J, et al. (2009). Targeted delivery of anti-coxsackievirus siRNAs using ligand-conjugated packaging RNAs. Antiviral Res. 83: 307-316. PMid:19616030   Zhou J, Shu Y, Guo P, Smith DD, et al. (2011). Dual functional RNA nanoparticles containing phi29 motor pRNA and anti-gp120 aptamer for cell-type specific delivery and HIV-1 inhibition. Methods 54: 284-294. PMid:21256218 PMCid:3107903   Zhu J (2010). Transcriptional regulation of Th2 cell differentiation. Immunol. Cell Biol. 88: 244-249. PMid:20065998 PMCid:3477614   Zhu J, Cote-Sierra J, Guo L and Paul WE (2003). Stat5 activation plays a critical role in Th2 differentiation. Immunity 19: 739-748.
N. Jiang, Zheng, Y. H., Chen, X. J., Qiu, C., Zhang, X. F., Wen, S. H., and Bian, G. X., Molecular cloning and functional characterization of a mouse ccl6 analog gene in the rat, vol. 11, pp. 3889-3898, 2012.
Aarvak T, Chabaud M, Kallberg E, Miossec P, et al. (1999). Change in the Th1/Th2 phenotype of memory T-cell clones from rheumatoid arthritis synovium. Scand. J. Immunol. 50: 1-9. PMid:10404044   Belperio JA, Dy M, Burdick MD, Xue YY, et al. (2002). Interaction of IL-13 and C10 in the pathogenesis of bleomycin-induced pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 27: 419-427. PMid:12356575   Berger MS, Kozak CA, Gabriel A and Prystowsky MB (1993). The gene for C10, a member of the beta-chemokine family, is located on mouse chromosome 11 and contains a novel second exon not found in other chemokines. DNA Cell Biol. 12: 839-847. PMid:8216854   Gerard C and Rollins BJ (2001). Chemokines and disease. Nat. Immunol. 2: 108-115. PMid:11175802   Han W, Lou Y, Tang J, Zhang Y, et al. (2001a). Molecular cloning and characterization of chemokine-like factor 1 (CKLF1), a novel human cytokine with unique structure and potential chemotactic activity. Biochem. J. 357: 127-135. PMid:11415443 PMCid:1221935   Han WL, Rui M, Zhang YM, Chen YY, et al. (2001b). Stimulatory effect of chemokine-like factor 1 (CKLF1) on the growth of bone marrow cells. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 23: 119-122. PMid:12905885   Ikadai H, Xuan X, Igarashi I, Tanaka S, et al. (1999). Cloning and expression of a 48-kilodalton Babesia caballi merozoite rhoptry protein and potential use of the recombinant antigen in an enzyme-linked immunosorbent assay. J. Clin. Microbiol. 37: 3475-3480. PMid:10523537 PMCid:85671   Kaesler S, Regenbogen J, Durka S, Goppelt A, et al. (2002). The healing skin wound: a novel site of action of the chemokine C10. Cytokine 17: 157-163. PMid:11895334   Li QJ, Lu S, Ye RD and Martins-Green M (2000). Isolation and characterization of a new chemokine receptor gene, the putative chicken CXCR1. Gene 257: 307-317.   Lou Y, Xia D, Han W, Wang Y, et al. (2003). Molecular cloning and characterization of rat chemokine-like factor 1 and 2. Gene 307: 125-132.   Nielsen H, Brunak S and von Heijne G (1999). Machine learning approaches for the prediction of signal peptides and other protein sorting signals. Protein Eng. 12: 3-9. PMid:10065704   Olson TS and Ley K (2002). Chemokines and chemokine receptors in leukocyte trafficking. Am. J. Physiol. Regul. Integr. Comp Physiol. 283: R7-28. PMid:12069927   Orlofsky A, Berger MS and Prystowsky MB (1991). Novel expression pattern of a new member of the MIP-1 family of cytokine-like genes. Cell Regul. 2: 403-412. PMid:1832565 PMCid:361810   Orlofsky A, Lin EY and Prystowsky MB (1994). Selective induction of the beta chemokine C10 by IL-4 in mouse macrophages. J. Immunol. 152: 5084-5091. PMid:8176224   Orlofsky A, Wu Y and Prystowsky MB (2000). Divergent regulation of the murine CC chemokine C10 by Th(1) and Th(2) cytokines. Cytokine 12: 220-228. PMid:10704248   Petrenko O, Ischenko I and Enrietto PJ (1995). Isolation of a cDNA encoding a novel chicken chemokine homologous to mammalian macrophage inflammatory protein-1 beta. Gene 160: 305-306.   Sarafi MN, Garcia-Zepeda EA, MacLean JA, Charo IF, et al. (1997). Murine monocyte chemoattractant protein (MCP)-5: a novel CC chemokine that is a structural and functional homologue of human MCP-1. J. Exp. Med. 185: 99-109. PMid:8996246 PMCid:2196097   Steinhauser ML, Hogaboam CM, Matsukawa A, Lukacs NW, et al. (2000). Chemokine C10 promotes disease resolution and survival in an experimental model of bacterial sepsis. Infect. Immun. 68: 6108-6114. PMid:11035713 PMCid:97687   Williamson PT, Roth JF, Haddingham T and Watts A (2000). Expression and purification of recombinant neurotensin in Escherichia coli. Protein Expr. Purif. 19: 271-275. PMid:10873541